Progress in prevention of perinatal HIV-1

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 86, Issue 421, 1997, Pages 97-103

  Fowler, M G ^a   Mofenson, L ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; PERINATAL INFECTION; PRENATAL CARE; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEVELOPING COUNTRY; DISEASE TRANSMISSION; FEMALE; HUMAN; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTI-HIV AGENTS; DEVELOPING COUNTRIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 0030848206     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Eng J Med 1994; 331: 1173-80
2. Centers for Disease Control and Prevention. US Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. Morbid Mortal Weekly Rep 1995; 44(RR-7): 1-15
3. Connor EM, Sperling R, Shapiro D, Oleske J, Fowler MG. Long term effect of zidovudine (ZDV) exposure among uninfected infants born to HIV-infected mothers in Pediatric AIDS Clinical Trials Group (ACTG) Protocol 076. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1995; 205: Abstract 11
4. Cooper ER, Nugent R, Diaz C, et al. After AIDS Clinical Trial 076: The changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. J Infect Dis 1996; 174: 1207-11
5. Fiscus SA, Adimora AA, Schoenbach VJ, Lim W, McKinney R, Rupar D, et al. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA 1996; 275: 1483-8
6. Wiznia AA, Crane M, Lamber G, Sansay J, Harris A, Solomon L. Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center. JAMA 1996; 275: 1504-6
7. WHO. AIDS: Images of the epidemic. Geneva: WHO, 1994
8. WHO. The current global situation of the HIV/AIDS pandemic. Geneva: WHO, 1995
9. Biggar RJ, Miotti PG, Taha TE, Mtimavalye L, Broadhead R, Justesen A, et al. The effect of a birth canal cleaning intervention to prevent perinatal HIV transmission. Lancet 1996. 347: 1647-50
10. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346: 530-6
11. Ammann AJ. Mother-infant HIV transmission: making the most of what we know. Nature Med 1996; 2: 490